Complex regional pain syndrome describes a constellation of symptoms that may involve the sympathetic nervous system. Emerging consensus recommends early intervention with spinal cord stimulation to facilitate physical therapy. Isolated case reports suggest this may be an effective treatment. Ten consecutive active duty United States military personnel with newly diagnosed complex regional pain syndrome underwent early intervention with spinal cord stimulation with favorable results, including decreased pain scores and decreased opioid intake. Six received injuries directly as a result of service in Iraq or Afghanistan. These patients also had posttraumatic stress disorder, but it did not interfere with successful pain control. Additionally, 6 of 10 patients continued on active duty. Compl ex regional pain syndrome (CRPS) is a clinical diagnosis based on criteria that include hyperalgesia, sudomotor, and trophic changes (1, 2) . It is differentiated by the presence or absence of major nerve damage as an inciting cause (1). The International Association for the Study of Pain changed the name of "reflex sympathetic dystrophy" to CRPS I, and "causalgia" to CRPS II, because not all pain in this spectrum is sympathetically maintained (1) . Repeated sympathetic blockade has been used to facilitate physical therapy (2-4). However, response to sympathetic blockade is partial or absent 73% of the time (2, 3, 5) . Likewise, surgical and radiofrequency sympathectomy provided effective pain relief in only 25% and 38% of patients at 1 yr (6, 7) . This may indicate a change from sympathetically mediated pain to sympathetically independent pain.
Spinal cord stimulation (SCS) is an effective therapy (3, 8, 9) , which promotes sympatholysis while preserving nociceptive pathways. This may explain its efficacy in treating early CRPS with features of sympathetically mediated pain (3, 8, 9) . SCS was originally considered an application of gate theory, which postulates that proprioceptive (A ␤) overload at the interneuron diminishes afferent nociceptive (polymodal C fiber) input (9,10,10a) . Recent investigations (11) (12) (13) (14) suggest more complicated, multimodal mechanisms of action, including neurotransmitter release and hyper-excited wide dynamic range neuron attenuation. The exact mechanism of action of the often dramatic response to SCS is unknown (3, 9, 11, 15) . The efficacy of SCS for CRPS diminishes modestly over time, but does not disappear (16) . As a result, early SCS treatment for CRPS is advocated (3, 11, 15) .
There is only one published randomized controlled trial for SCS in CRPS (9) . However, retrospective reviews and meta-analyses covering up to 5 yr of continuous treatment have validated SCS as an effective and economical treatment for CRPS (9,16 -19,19a) . Given the efficacy of SCS for CPRS and suggestions for early application we undertook early stimulation of 10 consecutive patients injured in military service.
METHODS
Ten consecutive patients underwent treatment in our Interventional Pain Center for CRPS Type I and II diagnosed by history and physical examination. Seven of our patients had lower extremity pain, whereas the remainder had either upper extremity or thoracic pain. Eight of our patients were male. The mean age was 27 Ϯ 7.4 yr. The mean duration of pain before trial of spinal cord stimulation was 9.9 Ϯ 2.5 mo. All patients had failed medical intervention, including gabapentinoids, tricyclic antidepressants, physical therapy, and other conservative treatments.
All patients underwent sympathetic blockade. In the eight patients, who demonstrated a sympathetically maintained component, defined as greater than 50% diminution of their pain and no appreciable motor block, without permanent resolution of symptoms, a minimum of two blocks were performed. The repeat block was timed if possible with a scheduled physical therapy appointment. In all these cases, the series of blocks, combined with physical therapy failed to permanently relieve or reverse the clinical findings of CPRS. The demographics, including mechanism of injury, are presented in Table 1 .
All patients who met criteria for posttraumatic stress disorder were followed by a psychiatrist. All patients underwent a trial of SCS lasting 5-7 days with devices from either Advanced Bionics (Valencia, CA) or Medtronic (Minneapolis, MN). The trial was considered successful in those who reported more than 50% of pain relief from baseline while using the stimulator. Compliance with physical therapy during the trial was interpreted as a positive predictor for implantation. Patients were referred to a behavioral psychologist to assess psychological optimization, including posttraumatic stress disorder (PTSD). Patients with somatization disorder were disqualified. All patients for implantation had favorable psychological screening. Following assessment, patients were implanted with dual-lead 16-electrode systems.
We retrospectively reviewed these patients' medical records and prepared this summary with consent of our Institutional Review Board. Routine assessment 3 mo and 6 mo after implantation included numeric rating scales (NRS) and opioid doses calculated in morphine equivalents. The changes from Pre-SCS NRS and opioid dose were then subjected to statistical evaluation using a two-tailed Student's t-test.
RESULTS
This retrospective, observational case series demonstrated a pooled mean NRS of 1.6 Ϯ 1.5 at 6 mo after spinal cord stimulator implantation, representing a decrease from a pre-SCS NRS of 7.8 Ϯ 1.3 (P Ͻ 0.001) (Fig. 1) . Mean daily morphine equivalents diminished from 103.5 Ϯ 79 to 22 Ϯ 15.8 mg (P ϭ 0.003) (Fig. 2) . In the war wounded cohort, pooled mean NRS decreased from 8 Ϯ 1.4 to 1.8 Ϯ 1.7 and morphine equivalent consumption decreased from 140 Ϯ 81 mg to 33.3 Ϯ 18.2 mg (P ϭ 0.004, P ϭ 0.02). The CRPS II subset showed a ␦ NRS of 6.5 Ϯ 2.3 (P Ͻ 0.001) and a decrease in opioid consumption of 81.67 Ϯ 17.2 mg (P ϭ 0.006). All patients became compliant with physical therapy.
DISCUSSION
American Civil War physician, Silas Weir Mitchell, is credited as the first modern physician to describe causalgia, (CRPS II). He wrote, "Long after every other trace of the effects of a wound has gone, these neuralgic symptoms are apt to linger, and too many carry them throughout the long years this final reminder of the battlefield." (20) ; His description of neuropathic war wounds still resonates. In the present Middle East conflict, improved armor protects vital areas including the head, neck, and thorax, resulting in a battlefield survival rate of approximately 90%. Injuries are mostly from improvised explosive device attacks, which cause survivable extremity wounds and traumatic amputation (21) . Along with physical injuries, most victims suffer PTSD, manifested by hypervigilance, sleep disturbance, and emotional lability (22) .
Recent consensus among experts suggests that using SCS earlier in the course of CRPS will improve quality of life and success of rehabilitation (3, 9, 11) . Based on the favorable responses to trial stimulation, we implanted SCS systems to encourage decreased opioid intake, facilitate rehabilitation, and importantly allow for repatriation with often distant commands and families. Six of our 10 patients were wounded as a result of service in Iraq or Afghanistan. One patient with CRPS I was stung by a scorpion, resulting in necrosis of the foot.
The war-wounded were injured in separate improvised explosive device attacks or motor vehicle crashes Mean age 27 Ϯ 7.4 yr; symptom duration before spinal cord stimulation 9.9 Ϯ 2.5 mo. SMP ϭ Sympathetically maintained pain, SIP ϭ sympathetically independent pain; PTSD ϭ posttraumatic stress disorder.
and had PTSD. These survivors had multiple extremity fractures and required repeated orthopedic procedures. Before consultation at our tertiary care Pain Center, all patients were noncompliant with physical therapy and were receiving moderately large doses of opioids. Typically, major psychological comorbidities, such as PTSD, may be considered disqualifying for SCS (23, 24) . However, all responded favorably to SCS, regardless of the presence of PTSD. Our results confirm that although sympathetically mediated pain may respond best to stimulation, sympathetically independent pain also responded well to SCS. Because only 2 of 10 patients had sympathetically independent pain, the data were not broken out for statistical analysis.
We conclude that early consideration for SCS should be given to those with CRPS, particularly CRPS II of Ͻ12 mo duration, whether there is a sympathetic component to their pain or not. SCS efficacy does not appear to be impaired by PTSD. Additional benefits of SCS appear to be decreased opioid use, improved compliance with physical therapy, and a short-term propensity toward retention of active duty military personnel. The enthusiasm with which these results may be applied to other populations should be tempered by the short period of follow-up in a small, retrospective observational case series. 
